Trial · NCT00445263
Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
NCT00445263, Phase 4, Terminated, Hospital Avicenne; results first posted 2015-02-09
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation. Trials, record NCT00445263. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00445263
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
- NCT number
- NCT00445263
- Status
- Terminated
- Phases
- Phase 4
- Enrollment
- 170 participants, actual
- Lead sponsor
- Hospital Avicenne
- Conditions
- CORONARY DISEASE
- Interventions
- TIROFIBAN, CORONAROGRAPHY
- First posted
- 2007-03-08
- Last updated
- 2015-02-27
- Results first posted
- 2015-02-09
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mortality, Myocardial Infarction and Revascularization in Emergency | d30 | |
| Secondary | Therapeutic Failure (Well Defined) During the First 6 Hours. Clinical Evolution and Electrocardiography | until the exit from the hospital and at d30. | |
| Secondary | Coronarographic Criteria : TIMI Score at the Beginning and the End of the Procedure; Existence of an Intra-coronary Thrombus | d30 | |
| Secondary | Troponin Peak. Left Ventricular Ejection Fraction Before Hospital Exit. Length of Stay in USIC and Hospital. Hemorrhagic Complications. | d30 |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Mortality, Myocardial Infarction and Revascularization in Emergency | d30 | participants | NUMBER | |
| SECONDARY | Therapeutic Failure (Well Defined) During the First 6 Hours. Clinical Evolution and Electrocardiography | until the exit from the hospital and at d30. | |||
| SECONDARY | Coronarographic Criteria : TIMI Score at the Beginning and the End of the Procedure; Existence of an Intra-coronary Thrombus | d30 | |||
| SECONDARY | Troponin Peak. Left Ventricular Ejection Fraction Before Hospital Exit. Length of Stay in USIC and Hospital. Hemorrhagic Complications. | d30 |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mortality, Myocardial Infarction and Revascularization in Emergency | Early Invasive Strategy | 2 | participants | ||
| Mortality, Myocardial Infarction and Revascularization in Emergency | Delayed Invasive Strategy | 21 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Early Invasive Strategy | 83 | |
| Overall Study | STARTED | Delayed Invasive Strategy | 87 | |
| Overall Study | COMPLETED | Early Invasive Strategy | 83 | |
| Overall Study | COMPLETED | Delayed Invasive Strategy | 86 | |
| Overall Study | NOT COMPLETED | Early Invasive Strategy | 0 | |
| Overall Study | NOT COMPLETED | Delayed Invasive Strategy | 1 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Major bleeding | General disorders | Early Invasive Strategy | 2 | 83 | |
| serious | Major bleeding | General disorders | Delayed Invasive Strategy | 1 | 86 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Early Invasive Strategy | ||
| Total, all-cause mortality | Delayed Invasive Strategy | ||
| Total, other adverse events | Early Invasive Strategy | 0 | 83 |
| Total, other adverse events | Delayed Invasive Strategy | 0 | 86 |
| Total, serious adverse events | Early Invasive Strategy | 2 | 83 |
| Total, serious adverse events | Delayed Invasive Strategy | 1 | 86 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Early Invasive Strategy vs Delayed Invasive Strategy: Mortality, Myocardial Infarction and Revascularization in Emergency | Trial comparisons |
| Early Invasive Strategy vs Delayed Invasive Strategy: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00445263
GET https://conductscience.org/api/trials/v1/NCT00445263/registered